About Iridex
A Wordwide Leader In The Treatment of Glaucoma
Iridex provides an array of established, laser-based procedures that expand ways to manage, preserve and prolong vision. Since 1989, we have been a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices, and consumable instrumentation for the treatment of glaucoma, diabetic macular edema (DME), and other retinal diseases. Our proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and durable procedures for targeted sight-threatening eye conditions. Iridex products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries.
Exective Leadership
David I. Bruce
President and CEO
Mr. Bruce currently serves as the President and Chief Executive Officer of the Company. He has served as a director of the Company since April 2018 and as President and Chief Executive Officer since May 2019. Mr. Bruce served as the Chief Operating Officer of Catheter Robotics, Inc., a private company focused on developing and manufacturing remote catheter systems from August 2014 to May 2016. From November 2011 to May 2014, Mr. Bruce served as President, Chief Executive Officer and director of Arstasis, Inc., a private company that manufactures and distributes vascular closure devices for arterial closure in catheterization procedures. Prior to that, Mr. Bruce served as CEO of EP MedSystems, a public medical device company specializing in electrophysiology systems and catheters, and led the company to 30% annual growth over two years culminating in its acquisition by St. Jude Medical. Mr. Bruce holds a B.S. in Mechanical Engineering from the University of California, Berkeley, and an MBA degree from the Wharton School at the University of Pennsylvania.
Mr. Bruce has extensive experience in the medical device industry. Mr. Bruce’s executive management and his past board service and consulting experience for the boards of directors of emerging medical device companies on market penetration strategy and execution, provide him with the necessary skills to serve as our President and Chief Executive Officer and on our Board.
Patrick Mercer
Chief Operating Officer
Mr. Mercer serves as our Chief Operating Officer. He joined the Company in 2018, bringing over 20 years of experience serving in multiple operational positions across various fields of the medical device industry. Prior to joining IRIDEX, he was Chief Operating Officer of Tracknet, a privately held LoRaWAN Internet of Things (IoT) solutions provider. Mr. Mercer also held leadership roles at privately held RODO Medical and DFINE. His global experience includes managing manufacturing operations in Hungary, China, Korea, Costa Rica, Germany, and Australia. Mr. Mercer graduated from the University of Alabama with a BSEE in Electrical Engineering / Computer Engineering. He also proudly served in the elite Nuclear Power Program for the US Navy.
Bassem BouHabib
Vice President, International Sales
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Patrick Breen
Vice President, Retina US Sales
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Kevin McMahon
Vice President, Glaucoma US Sales
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Ken Arnold
Vice President, Engineering
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
IRIDEX Cares
We have had a long-standing commitment to saving sight worldwide. We feel passionate about building key community partnerships with groups that share our mission to fight blindness, improve quality of care, and make a difference in patients’ lives. For this reason, we often support missions to areas with high need. We are proud that our equipment is helping surgeons who care bring light back to glaucoma sufferers more safely, more quickly, and more successfully than ever before.
Board of Directors
Robert Gunst
Chairman
Mr. Gunst has served as a director of the Company since July 2019. Mr. Gunst served on the Board of Directors of Natus Medical from June 2004 to June 2019, serving as its Chairman from September 2004 until July 2018. Currently a private investor, Mr. Gunst served from 1990 to 1999 as President and Chief Executive Officer of The Good Guys, Inc. Earlier in his career, he held executive positions at several large corporations, including Shaklee Corporation, La Petite Boulangerie, Inc. and PepsiCo Foods (Frito Lay) International (both subsidiaries of PepsiCo, Inc.), Victoria Station Incorporated and The First National Bank of Chicago. Mr. Gunst has served on a variety of public and private boards, including serving as a Director of The Good Guys, Inc. from 1986 to 1999, Director of Phoenix Footwear Group, Inc. from 2006 to 2007, Director of PortalPlayer, Inc. from 2005 to 2007, Director of AmNet Mortgage, Inc. (formerly American Residential Investment Trust Inc.) from 2004 to 2005, Director of Garden Fresh Restaurant Corp. from 1996 to 2004 and Chairman of Garden Fresh Restaurant Corp. from 2003 to 2004. He served as a member of the Deans Advisory Council of the Graduate School of Management at the University of California, Davis from 1997 to 2008. Mr. Gunst holds an MBA in Finance from the University of Chicago’s Graduate School of Business and an A.B. in Economics from Dartmouth College.
Doris Engibous
Director
Ms. Engibous has served as a director of the Company since April 2020. Ms. Engibous currently serves as a consultant and advisor to medical technology companies and executives. Since 2019, Ms. Engibous has served on the board of directors of Imricor Medical Systems Inc., a company focused on developing and manufacturing MRI-compatible products for cardiac catheter ablation procedures. From 2004 to 2018, Ms. Engibous served on the board of directors of Natus Medical Incorporated, a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Since 2014, she has also served on the board of directors of GI Supply Inc, a provider of endoscopic tattoo technology for clinical surveillance and surgical localization of the colon. She has also held positions with Hemosphere Inc. (purchased by CryoLife Inc.), Nellcor Inc. (now part of Medtronic plc), and the American Hospital Supply Corporation (acquired by Baxter International Inc.). She holds a Bachelor of Science degree in Chemical Engineering from the University of Michigan.
David I. Bruce
Director
Mr. Bruce currently serves as the President and Chief Executive Officer of the Company. He has served as a director of the Company since April 2018 and as President and Chief Executive Officer since May 2019. Mr. Bruce served as the Chief Operating Officer of Catheter Robotics, Inc., a private company focused on developing and manufacturing remote catheter systems from August 2014 to May 2016. From November 2011 to May 2014, Mr. Bruce served as President, Chief Executive Officer and director of Arstasis, Inc., a private company that manufactures and distributes vascular closure devices for arterial closure in catheterization procedures. Prior to that, Mr. Bruce served as CEO of EP MedSystems, a public medical device company specializing in electrophysiology systems and catheters, and led the company to 30% annual growth over two years culminating in its acquisition by St. Jude Medical. Mr. Bruce holds a B.S. in Mechanical Engineering from the University of California, Berkeley, and an MBA degree from the Wharton School at the University of Pennsylvania.
Mr. Bruce has extensive experience in the medical device industry. Mr. Bruce’s executive management and his past board service and consulting experience for the boards of directors of emerging medical device companies on market penetration strategy and execution, provide him with the necessary skills to serve as our President and Chief Executive Officer and on our Board.
Robert Grove, Ph.D.
Director
Dr. Grove became a director in 2018. He currently sits on the Membership Committee of the American Society for Laser Medicine and Surgery, and as an advisor to several emerging medical device companies. Most recently he served as Executive Chairman for the start-up ON Light Sciences, a manufacturer of transparent gel patches for accelerated tattoo removal that was acquired by Merz North America in 2016. Dr. Grove was co-founder of TRIA Beauty and served as that company’s Chief Executive Officer and Chief Technology Officer. Prior to TRIA Beauty, he co-founded Star Medical Technologies, negotiated its acquisition by Coherent and continued as president of Coherent Star. Dr. Grove’s extensive career in laser technology also included leadership roles at DermaCare, Inc., Cooper LaserSonics, Inc., and Plasma Kinetics, Inc. He began his career as a project leader for the Lawrence Livermore National Laboratory. Grove holds a Ph.D. in Instrumentation in the field of laser applications and an M.S. in Aeronautics and Astronautics from MIT, and is a named inventor on 25 issued U.S. patents in the medical and laser fields.
Kenneth E. Ludlum
Director
Mr. Ludlum has served as a director of the Company since April 2019. Mr. Ludlum also serves on the board and as Chairman of the Audit Committee for NATUS Medical, a publicly held medical device company and at Personalis, Inc., a venture backed molecular diagnostics company and on the board of directors and as Chairman of the Audit Committee of Dermavant Sciences Limited, a United Kingdom company. Previously, he served on the board of directors for Novacept Corporation, Thermage Corporation, AtheroMed, Bridgeway Plan for Health and Kinetikos Medical. He also served as Chief Financial Officer of CareDx, a molecular diagnostics company, through the company’s initial public offering in 2014. Prior to that, he served in executive roles at several medical device companies, including President and CEO of Revivant Corporation and CFO of Perclose Inc. This wealth of relevant experience in the medical technology sector including the leadership roles as board member, executive officer, investor, and advisor makes Mr. Ludlum an ideal board member. Mr. Ludlum holds a B.S. in Business Administration from Lehigh University and a M.B.A. from Columbia University Graduate School of Business.
Scott Shuda
Director
Mr. Shuda has served as a director of the Company since April 2019. Mr. Shuda has been a member of the board of directors of InfuSystem Holdings, Inc. (“InfuSystem”), a provider of ambulatory infusion pumps, since September 2016, and was elected chairman on the board of InfuSystem in December 2018. Mr. Shuda is a Managing Director and Co-founder of Meridian OHC Partners, LP and BlueLine Partners, LLC, investment firms that focus on publicly listed technology and healthcare companies. Mr. Shuda previously served on our Board, from December 2012 to April 2017. Mr. Shuda holds both a J.D. and an MBA from Georgetown University.
